This site uses cookies to enhance your browsing experience. By continuing navigation, you agree to the use of cookies. For more information about our use of cookies, see our Privacy Policy.

Endotronix COVID-19 Company Statement

April 2, 2020 | Press Release

Remote, proactive care to keep HF patients healthy and at home.

During these unprecedented times, it is our goal to reduce unnecessary exposure for patients and clinicians while allowing care teams to better manage heart failure symptoms before they escalate. Together with our clinician partners, we can, and will, provide remote heart failure management for this vulnerable population.

Our efforts extend to the Endotronix family where we have optimized workplace operations to incorporate social distancing and remote working practices in our continued commitment to excellence in customer support while keeping our employees safe.

We applaud the heroic efforts of healthcare providers, working hard every day on behalf of patients.  With today’s increased personal risk of COVID-19 exposure, this is exponentially magnified. Our healthcare partners have realized the importance of remote heart failure management long before this pandemic began. The current situation heightens the urgency of transitioning to remote management to minimize unnecessary clinic and ER visits. In addition, remote management minimizes the risk of cross infection and, when used with guideline directed care, may slow the disease progression.  At Endotronix, we are here to ensure a smooth transition to remote heart failure management, providing exceptional patient management and care.

Top